The FDA and Pfizer wanted to keep the vaccine trial results hidden for up to 75 years. Now we know why. There are some quite serious anomalies that are begging for answers.

One such example is the fact that the lead author on the seminal vaccine paper in the New England Journal of Medicine (NEJM), one Fernando Polack, MD, just happened to be the only investigator in charge of a site in Argentina that purportedly managed to recruit 4,501 patients in just three weeks!

Is this even possible with a full team and the backing of a major contract research organization (CRO)? It's quite the feat and it needs to be investigated and answers given.

Without more transparency some might be left wondering if perhaps there was fraud involved or that perhaps patient records were sloppy because the on-boarding pace was too rapid. Regardless, no such questions should ever be part of the landscape, especially not when it involves a brand new medical intervention platform (mRNA) that was mandated as a condition of continued education and/or employment.